Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Brent Pfeiffenberger

Brent Pfeiffenberger is recorded as CEO and Chairman at Century Therapeutics, Inc. (IPSC) and Board Member at Corbus Pharmaceuticals Holdings, Inc. (CRBP). Corbus Pharmaceuticals Holdings, Inc. reported in an 8-K filed May 14, 2026 that Brent Pfeiffenberger was appointed member of the Board, effective May 13, 2026. Century Therapeutics, Inc. reported in an 8-K filed November 14, 2023 that Brent Pfeiffenberger was appointed member of the Board, effective December 4, 2023. Century Therapeutics, Inc. reported in an 8-K filed November 14, 2023 that Brent Pfeiffenberger was appointed President and Chief Executive Officer, effective December 4, 2023.

“On May 13, 2026, the board of directors (the "Board") of Corbus Pharmaceuticals Holdings, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Brent Pfeiffenberger, age 48, to serve as a member of the Board, thereby expanding the Board to seven members.”
Corbus Pharmaceuticals Holdings, Inc. Form 8-K, filed May 14, 2026 · Read the filing
“Concurrently with his appointment as President and Chief Executive Officer and effective as of the Effective Date, Dr. Pfeiffenberger was appointed to serve as a member of the Board and the size of the Board will increase to eight directors.”
Century Therapeutics, Inc. Form 8-K, filed November 14, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Century Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Corbus Pharmaceuticals Holdings, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.